KRAS and neoplasm: Moreover, Storz et al. identified the Kras mutation as a mediator of ICAM-1 upregulation that attracts M1-polarized macrophages and promotes secretion of pro-inflammatory cytokines and proteases, also leading to tumor progression [43].